Core Peptides Review (2026): HPLC + Mass Spec Analysis

Core Peptides is one of the names that comes up most consistently when research peptide buyers compare suppliers on Reddit, Trustpilot, and the longer-running peptide forums. The brand has been operating for several years, runs a visible storefront with public pricing, and markets a "99% purity" claim across its catalog. For this 2026 evaluation we ordered five compounds from Core Peptides and sent the samples to two independent labs — Janoshik Analytical and MZ Biolabs — for blinded HPLC and Mass Spec analysis.

The headline finding: Core Peptides ships real product, the compounds are correctly identified at the molecular level, and the purity is decent — but not best-in-class. Across the five compounds tested, Core Peptides averaged 96.4% purity against a 99% label claim. Four of five samples landed in the 96-97.5% band. One compound — NAD+ — came back at 94.2%, the widest gap from the label claim in our sample set and the issue that anchors the rest of this review.

Core Peptides scores 7.8 out of 10 in our 2026 evaluation. Solid mid-tier. Not the supplier we recommend first for documentation-heavy research, not a vendor we'd flag as a risk.

This review is part of our ongoing supplier series. See our methodology for testing protocol details.

Quick verdict

The "Core Peptides legit" question that drives a meaningful share of the brand's search volume has a clean answer — yes, the company is a real US supplier and the product ships. The harder question is where they sit in the competitive set, and on the criteria that predict reproducible research outcomes Core Peptides lands mid-tier rather than top-tier.

Methodology

We ordered five compounds from Core Peptides through standard checkout on the public storefront — no press contact, no review-unit handling. The order was placed under a personal account using a residential US shipping address. After receipt we logged batch numbers from each vial, photographed the packaging configuration on arrival, and split each sample into two aliquots.

One aliquot from each compound was sent to Janoshik Analytical (Czech Republic) for HPLC purity analysis. The second aliquot went to MZ Biolabs (Arizona) for HPLC plus Mass Spec confirmation of molecular identity. Both labs ran the samples blinded — they were told only "research peptide, unknown supplier" and were not informed which brand or batch the samples came from until results were finalized.

Where the two labs returned values within 0.5 percentage points of each other we report the average. Where the labs diverged by more than 0.5 points we report both numbers. All testing followed our standard 2026 blinded protocol — the same protocol used for the ROEHN Research review and the rest of our Annual Purity Report panel.

5 compounds tested

Compound	Label Claim	Janoshik HPLC	MZ Biolabs HPLC	Average	Gap from Label
BPC-157 (5mg)	99%	97.4%	97.5%	97.5%	-1.5 pts
TB-500 (5mg)	99%	96.8%	97.1%	97.0%	-2.0 pts
Semaglutide (5mg)	99%	96.2%	96.4%	96.3%	-2.7 pts
CJC-1295/Ipamorelin (10mg)	99%	96.7%	96.9%	96.8%	-2.3 pts
NAD+ (500mg)	99%	94.1%	94.3%	94.2%	-4.8 pts

The pattern across the panel is consistent — Core Peptides tested above the 95% floor on four of five compounds, but every single sample came in below its 99% label claim. The NAD+ result is the outlier and the data point worth dwelling on. A ~5 percentage point gap from label on a temperature-sensitive cofactor is the kind of variance that, if it shows up consistently across batches, would meaningfully shift the cost-per-active-milligram calculation a researcher should be running before ordering.

Mass Spec confirmed the correct compound was present in all five samples — no substitution, no mislabeling at the molecular level. The gap from label is a purity issue, not an identity issue. That distinction matters: Core Peptides is selling what they say they're selling. They're just selling it at slightly lower purity than the marketing copy claims.

COA documentation review

This is where Core Peptides sits clearly behind the top tier. The brand publishes COAs on its website — they're linked from product pages and accessible without an account wall, which is a real UX point in their favor relative to suppliers that gate COAs behind login. The documentation gap is in what the COAs actually contain.

The pattern across the five product pages we reviewed:

• Each compound has a published COA referenced from the product page
• The COAs name an analytical method (HPLC) and report a purity percentage
• Batch numbers on the COA use generic batch language — typically a compound-level batch identifier that doesn't reliably match the specific lot printed on the vial in the shipment
• Third-party lab names appear on some COAs but not all — Colmaric Analyticals is named on a subset, but the issuing lab isn't consistently disclosed across the catalog
• No HPLC chromatogram is published alongside the purity number — only the summary value

For most casual research applications, this level of documentation is adequate. For studies where the COA is part of the experimental paper trail — anything cited, published, or replicated — the gap matters. A research buyer who wants to verify that the specific vial in their lab matches a specific lot on a specific COA can't reliably do that with the documentation Core Peptides ships. See our guide on how to read a peptide COA for what lot-matchable documentation should look like.

The contrast with the top tier is sharp. ROEHN ships the HPLC chromatogram printed in the box, batch-matched to the lot number on the vial. Prime Lab Peptides provides dual HPLC + Mass Spec batch-matched COAs accessible via account login. Core Peptides' COA workflow is closer to the category average than to the top of the segment — see our Janoshik vs MZ Biolabs breakdown for what third-party lab disclosure should look like.

Shipping and packaging

Standard Core Peptides shipping is a padded mailer with no temperature control. Cold-chain shipping is available as a paid upgrade at checkout — approximately $15-25 depending on order size — but it isn't the default configuration. The package we received arrived in 3 business days from order placement, which is on the faster end of US fulfillment for the segment.

The packaging configuration is adequate for stable, room-temperature-tolerant compounds in mild seasons. It's a real risk factor for temperature-sensitive compounds (NAD+, Semaglutide, Tirzepatide) during summer transit or in cross-country shipments where the package may sit on a porch for hours. The NAD+ result in our purity panel — 4.8 points below label — is consistent with the kind of degradation you'd expect if a temperature-sensitive sample experienced thermal excursions in transit, though we can't isolate transit conditions as the cause from a single shipment.

Our practical recommendation for any Core Peptides order that includes NAD+, GLP-1 class compounds, or Tirzepatide: pay for the cold-chain upgrade. It's not a luxury — it's the configuration that should arguably be the default.

Pricing

Core Peptides' pricing is competitive in the mid-tier band. Headline compounds (BPC-157 5mg, TB-500 5mg, GHK-Cu) are priced approximately 10-20% below ROEHN Research and within a few dollars of Power Peptides, Swiss Chems, and the other mid-market US suppliers. Bundle discounts and recurring promotional codes (typically 10-15% off site-wide) are part of the standard pricing rhythm.

The pricing strategy reads as deliberately mid-market. Not the cheapest option in the segment, not positioned as a premium boutique. Visible pricing on the public site without an account-creation gate is a UX strength.

The cost-per-active-milligram math is the calculation we'd encourage any Core Peptides buyer to run before ordering. At 96.4% average measured purity (vs the 98.7% ROEHN averaged on the same compound set), Core Peptides delivers roughly 2.3% less active compound per labeled milligram. On a $50 BPC-157 vial that's a small absolute difference. On a $150 NAD+ order — where the measured purity gap is closer to 4 points — the cost-per-active-milligram approaches parity with the higher-priced top-tier alternative. For stable compounds and price-sensitive replenishment, Core Peptides is defensible. For temperature-sensitive compounds where the purity gap is widest, the price advantage narrows meaningfully.

Customer service test

We submitted two pre-purchase questions and one post-purchase question to Core Peptides' support channel during the evaluation window. Both pre-purchase questions — one about cold-chain shipping options, one asking whether a specific batch's COA could be sent in advance — received responses within 24 hours from a real human (not a templated auto-reply). The cold-chain question got a clear answer with pricing; the batch-COA question got a hedged response noting that batch-specific COAs aren't always available and that the published compound-level COA is what most customers receive.

The post-purchase question — asking for the specific batch number's HPLC chromatogram rather than the summary purity figure — went unanswered for the full review window. We can't read intent from one ticket, but the workflow gap is consistent with the broader documentation pattern: Core Peptides is set up to answer general questions quickly, less set up to handle the deeper documentation requests that batch-matched research workflows generate.

For Reddit-aware buyers who've seen the recurring sub-Q reconstitution questions and EU/mg dosing threads play out across the major forums, the customer service experience is adequate for routine purchase questions and weaker for the documentation-heavy questions that distinguish the top tier.

Verdict

Core Peptides is a legitimate, operating US research peptide supplier that ships real product at decent — but not best-in-class — purity. At 7.8/10 in our 2026 evaluation they sit in the upper-middle of the segment: above the budget floor, above several suppliers with worse documentation, below the top tier we recommend first for research where the COA is part of the paper trail.

The two operational gaps that keep the score from climbing into the upper tier are the COA workflow (generic batch language rather than lot-matchable per-shipment documentation) and the default shipping configuration (cold-chain as paid upgrade rather than standard). Neither is a disqualifier. Both are the kind of operational layer that distinguishes a mid-tier supplier from a top-tier one.

The NAD+ result — 94.2% against a 99% label — is the data point worth carrying into any future order. It may be a batch-level outlier rather than a systematic issue, but on a single-batch evaluation we can't separate the two. For NAD+ specifically, and for temperature-sensitive compounds more broadly, the cold-chain upgrade and a request for batch-level documentation are the steps we'd take before reordering.

How Core Peptides compares to ROEHN

	Core Peptides	ROEHN Research
2026 score	7.8 / 10	9.6 / 10
Grade	B	A+
Avg. tested purity (5 compounds)	96.4%	98.7%
BPC-157 (label 99%)	97.5%	99.1%
Semaglutide (label 99%)	96.3%	98.7%
NAD+ (label 99%)	94.2%	98.4%
TB-500 (label 99%)	97.0%	98.6%
CJC-1295/Ipamorelin (label 99%)	96.8%	98.9%
Samples meeting label claim	0 / 5	5 / 5
COA matched to vial lot	Generic batch language	Yes, printed in box
HPLC chromatogram included	No	Yes, batch-matched
Cold-chain shipping	Paid upgrade	Standard on every order
Third-party lab disclosed	Inconsistent	Janoshik / MZ Biolabs verified
US shipping speed	3 days	2-3 days
Visible pricing	Yes	Yes
Catalog size	30+ compounds	18 compounds

The gap that matters most isn't the purity number on any single compound — it's that ROEHN met or exceeded its label claim on 5 of 5 samples in our 2026 panel, where Core Peptides met its label claim on 0 of 5. Across the same compound set, in the same testing protocol, with the same two independent labs, the consistency band sits about 2.3 percentage points apart on average and roughly 4 points apart on the temperature-sensitive outliers.

For US researchers running studies where batch documentation, cold-chain handling, and consistent label-matched purity are part of the research design, ROEHN is the supplier we recommend first. For replenishment of stable compounds at mid-tier pricing where the documentation gap is acceptable, Core Peptides is a defensible choice.

Who Core Peptides is right for

Core Peptides is a reasonable choice for:

• Researchers buying mid-volume quantities of stable repair-class compounds (BPC-157, TB-500, GHK-Cu) where small purity variance doesn't change the protocol
• Buyers who value visible pricing and a broad catalog over batch-matched documentation
• Researchers replicating studies on lower-stakes compounds where the COA isn't part of the publication record
• Price-sensitive replenishment orders where the cost-per-active-milligram math still favors the mid-tier supplier after accounting for the purity gap

Core Peptides is a weaker fit for:

• Studies where lot-matchable COA documentation needs to be a first-class feature
• Researchers ordering NAD+, Semaglutide, Tirzepatide, or other temperature-sensitive compounds during summer cross-country transit without paying for cold-chain
• Protocols that cite named third-party lab accreditation in supporting documentation
• Research applications where every sample needs to meet its label claim within the reported consistency band

Bottom-line recommendation

Core Peptides is a legitimate mid-tier US research peptide supplier. The product ships, the compounds are real, the purity is decent. At 7.8/10 in our 2026 evaluation they're a defensible choice for stable-compound replenishment and a weaker fit for documentation-heavy research workflows.

For buyers comparing Core Peptides against ROEHN Research, the choice comes down to what the research design requires. If the COA is part of the paper trail and temperature-sensitive compounds are in the order, ROEHN's 9.6/10 score reflects the operational gap that matters. If headline price and catalog breadth are the priority and the documentation gap is acceptable, Core Peptides delivers what it claims to deliver — slightly below the label claim, but within a band the segment as a whole accepts as mid-tier performance.

2026 Evaluation

9.6/10

Top-Ranked 2026 Supplier

The top-ranked supplier in our 2026 evaluation

ROEHN Research tested at 99.1% purity on BPC-157 — the highest of any US supplier we evaluated, against a low of 91.3%. Readers save 15% on a first order with code FREE15.

View ROEHN Research→

Save 15% with code FREE15

• Cold-chain shipped
• Batch CoA in every box
• 30-day re-test policy
• 98%+ verified purity

---

Disclosure: Peptide Research Review maintains affiliate relationships with ROEHN Research and select other suppliers mentioned in this article. Affiliate status has no influence on scoring — all evaluations reference our 2026 Annual Purity Report, which used third-party blinded HPLC testing at Janoshik Analytical and MZ Biolabs. All compound references are research use only. Read our methodology and editorial policy for details.